Amneal Pharmaceuticals Inc (NASDAQ: AMRX) is -11.87% lower on its value in year-to-date trading and has touched a low of $5.18 and a high of $9.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMRX stock was last observed hovering at around $6.97 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $6.98, the stock is -13.57% and -15.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.81 million and changing 0.14% at the moment leaves the stock -14.07% off its SMA200. AMRX registered 22.46% gain for a year compared to 6-month gain of -19.59%. The firm has a 50-day simple moving average (SMA 50) of $8.2185 and a 200-day simple moving average (SMA200) of $8.122975.
The stock witnessed a -20.59% loss in the last 1 month and extending the period to 3 months gives it a -12.42%, and is -5.42% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.28% over the week and 4.92% over the month.
Amneal Pharmaceuticals Inc (AMRX) has around 8300 employees, a market worth around $2.19B and $2.79B in sales. Fwd P/E is 8.73. Profit margin for the company is -4.18%. Distance from 52-week low is 34.75% and -26.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.45%).
with sales reaching $715.49M over the same period.The EPS is expected to grow by 17.24% this year, but quarterly earnings will post 8.34% year-over-year. Quarterly sales are estimated to grow 8.54% in year-over-year returns.
Amneal Pharmaceuticals Inc (AMRX) Top Institutional Holders
271.0 institutions hold shares in Amneal Pharmaceuticals Inc (AMRX), with institutional investors hold 80.36% of the company’s shares. The shares outstanding are 309.88M, and float is at 137.45M with Short Float at 3.22%. Institutions hold 41.26% of the Float.
The top institutional shareholder in the company is UBS GROUP AG with over 21.85 million shares valued at $138.74 million. The investor’s holdings represent 7.0684% of the AMRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 13.99 million shares valued at $88.86 million to account for 4.5542 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 12.33 million shares representing 3.9884% and valued at over $78.29 million, while BLACKROCK INC. holds 3.6499 of the shares totaling 11.28 million with a market value of $71.64 million.
Amneal Pharmaceuticals Inc (AMRX) Insider Activity
The most recent transaction is an insider sale by Patel Gautam, the company’s Director. SEC filings show that Patel Gautam sold 80,000 shares of the company’s common stock on Apr 01 ’25 at a price of $8.30 per share for a total of $0.66 million. Following the sale, the insider now owns 1.73 million shares.
Amneal Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 14 ’25 that Patel Tushar Bhikhubhai (10% Owner) sold a total of 5,000,000 shares of the company’s common stock. The trade occurred on Mar 14 ’25 and was made at $8.35 per share for $41.75 million. Following the transaction, the insider now directly holds 48.58 million shares of the AMRX stock.
Still, SEC filings show that on Mar 14 ’25, Patel Tushar Bhikhubhai (10% Owner) Proposed Sale 5,000,000 shares at an average price of $8.75 for $43.75 million. The insider now directly holds shares of Amneal Pharmaceuticals Inc (AMRX).
